Skip to main content

Table 1 Demographics and characteristics of 163 breast cancer patients with a second primary malignancy, n (%)

From: Predictive models for overall survival in breast cancer patients with a second primary malignancy: a real-world study in Shanghai, China

Variable

Total number (N = 163)

Latency (years)

p

 ≤ 5 (n = 77)

 > 5 (n = 86)

Age of BC diagnosis (years)

56.47 ± 11.62a

   

  < 56

102 (62.58)

50 (64.94)

52 (60.47)

0.556

  ≥ 56

61 (37.42)

27 (35.06)

34 (39.53)

 

Age of SPM diagnosis (years)

62.42 ± 11.99a

  

0.418

  < 62 (ref)

94 (57.67)

63 (60.00)

31 (53.45)

 

  ≥ 62

69 (42.33)

42 (40.00)

27 (46.55)

 

TNM stage of BC

   

0.123

  I + II

119 (73.01)

62 (80.52)

57 (66.28)

 

  III + IV

12 (7.36)

4 (5.19)

8 (9.30)

 

  Unclassified

32 (19.63)

11 (14.29)

21 (24.42)

 

TNM stage of SPM

   

0.161

  I + II

59 (36.20)

33 (42.90)

26 (30.23)

 

  III + IV

36 (22.10)

13 (16.88)

23 (26.74)

 

  Unclassified

68 (41.72)

31 (40.26)

37 (43.02)

 

BC therapeutic hospital grade

    

  Secondary

62 (38.04)

30 (38.96)

32 (37.21)

0.818

  Tertiary

101 (61.96)

47 (61.04)

54 (62.79)

 

SPM therapeutic hospital grade

    

  Secondary

38 (23.31)

16 (20.78)

22 (25.58)

0.469

  Tertiary

125 (76.69)

61 (79.22)

64 (74.42)

 

Surgery for BC

   

0.001

  Yes

80 (49.07)

47 (61.04)

33 (38.37)

 

  No

58 (35.58)

26 (33.76)

32 (37.21)

 

  Unknown

25 (15.34)

4 (5.19)

21 (24.42)

 

Surgery for SPM

   

0.653

  Yes

43 (55.84)

45 (52.33)

88 (53.99)

 

  No

75 (46.01)

34 (44.16)

41 (47.67)

 

SPM sites

   

0.004

  Colon and rectum

30 (18.40)

12 (15.58)

18 (20.93)

 

  Thyroid

28 (17.18)

22 (28.57)

6 (6.98)

 

  Lung and bronchus

24 (14.72)

9 (11.69)

15 (17.44)

 

  Others

81 (49.69)

34 (44.16)

47 (54.65)

 

Total number of patients

163 (100.00)

77 (47.24)

86 (52.76)

 
  1. BC breast cancer, TNM tumour node metastasis, SPM second primary malignancy
  2. aMean ± SD